In Brief: Minntech
This article was originally published in The Gray Sheet
Minntech: Week-long FDA investigation of firm's fiber and dialyzer production facilities "did not find any evidence to support...allegations of noncompliance made by former employees," Minntech says in an Oct. 28 release. Two administrative deficiencies were found, however. One had been corrected prior to the audit, and "a plan for correction has been submitted for the other," the firm says...
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.